Circadian Rhythm Sleep Disorders Clinical Trial
Official title:
A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of VEC-162 on Circadian Rhythm in Healthy Subjects
The purpose of this study is to assess the safety and efficacy of VEC-162 compared to matching placebo on circadian phase shift and sleep parameters.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02776215 -
Study of the Pharmacokinetics and Safety of Tasimelteon in Children and Adolescents
|
Phase 1 | |
Suspended |
NCT00427323 -
Light Exposure to Treat Sleep Disruption in Older People
|
N/A |